Supply Chain Strategies for New Therapies
Autologous engineered T-cell therapies challenge traditional late stage and commercial pharma supply chains practices
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals